Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ligand Pharmaceuticals (LGND) Other Non-Current Assets: 2010-2024

Historic Other Non-Current Assets for Ligand Pharmaceuticals (LGND) over the last 15 years, with Dec 2024 value amounting to $6.9 million.

  • Ligand Pharmaceuticals' Other Non-Current Assets fell 67.03% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year decrease of 67.03%. This contributed to the annual value of $6.9 million for FY2024, which is 8.32% up from last year.
  • According to the latest figures from FY2024, Ligand Pharmaceuticals' Other Non-Current Assets is $6.9 million, which was up 8.32% from $6.4 million recorded in FY2023.
  • Ligand Pharmaceuticals' Other Non-Current Assets' 5-year high stood at $270.8 million during FY2021, with a 5-year trough of $1.7 million in FY2022.
  • Its 3-year average for Other Non-Current Assets is $5.0 million, with a median of $6.4 million in 2023.
  • Per our database at Business Quant, Ligand Pharmaceuticals' Other Non-Current Assets skyrocketed by 6,245.98% in 2021 and then slumped by 99.36% in 2022.
  • Yearly analysis of 5 years shows Ligand Pharmaceuticals' Other Non-Current Assets stood at $4.3 million in 2020, then skyrocketed by 6,245.98% to $270.8 million in 2021, then tumbled by 99.36% to $1.7 million in 2022, then soared by 268.20% to $6.4 million in 2023, then increased by 8.32% to $6.9 million in 2024.